Matthew H Rim

Northwestern Medicine — United States

Medicine · Health Sciences

10h-index434citations30works6.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical studies and practices(12), Pharmaceutical Practices and Patient Outcomes(11), Pharmaceutical Economics and Policy(11), Medication Adherence and Compliance(7), Biosimilars and Bioanalytical Methods(7)

Publications30 total

Recent and anticipated novel drug approvals (4Q 2025 through 3Q 2026)
American Journal of Health-System Pharmacy·2025· 1 cited
Recent and anticipated novel drug approvals (3Q 2025 through 2Q 2026)
American Journal of Health-System Pharmacy·2025· 1 cited
Recent and anticipated novel drug approvals (2Q 2025 through 1Q 2026)
American Journal of Health-System Pharmacy·2025· 2 cited
National trends in prescription drug expenditures and projections for 2025
American Journal of Health-System Pharmacy·2025· 6 cited
Recent and anticipated novel drug approvals (1Q 2025 through 4Q 2025)
American Journal of Health-System Pharmacy·2025· 4 citedOpen Access
Recent and anticipated novel drug approvals (4Q 2024 through 3Q 2025)
American Journal of Health-System Pharmacy·2024· 5 cited
Recent and anticipated novel drug approvals (3Q 2024 through 2Q 2025)
American Journal of Health-System Pharmacy·2024· 5 cited
Recent and anticipated novel drug approvals (Q2 2024 through Q1 2025)
American Journal of Health-System Pharmacy·2024· 4 cited
Conversion of an outpatient pharmacy to a mail-order pharmacy within a health system
American Journal of Health-System Pharmacy·2024· 1 cited
National trends in prescription drug expenditures and projections for 2024
American Journal of Health-System Pharmacy·2024· 38 cited
Recent and anticipated novel drug approvals for 2024
American Journal of Health-System Pharmacy·2024· 7 cited
Recent and anticipated novel drug approvals for 2023 and 2024
American Journal of Health-System Pharmacy·2023· 2 cited
Recent and anticipated novel drug approvals for 2023 and 2024
American Journal of Health-System Pharmacy·2023· 5 cited
Development of a framework to support data-driven decision-making in a health-system specialty pharmacy
American Journal of Health-System Pharmacy·2023· 1 cited
National trends in prescription drug expenditures and projections for 2023
American Journal of Health-System Pharmacy·2023· 50 citedOpen Access
HEALTH SYSTEM SPECIALTY PHARMACY
ASHP eBooks·2022
Virtualization and standardization of a health-system specialty pharmacy call center
American Journal of Health-System Pharmacy·2022· 1 cited
National trends in prescription drug expenditures and projections for 2022
American Journal of Health-System Pharmacy·2022· 64 citedOpen Access
Charting a course for health-system specialty pharmacy
American Journal of Health-System Pharmacy·2021· 3 cited
National trends in prescription drug expenditures and projections for 2021
American Journal of Health-System Pharmacy·2021· 45 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Andrew M Levitsky(10), Eric M. Tichy(7), James M. Hoffman(7), Mina Tadrous(7), Sandra Cuéllar(7), Glen T. Schumock(7), John Spencer Clark(6), Brittany L Karas(6), Farah Barada(6), Katie J. Suda(5), Karen C. Thomas(5), Nancy A. Nickman(4), Lorraine K. Tyler(4), Collin Dean(4), Michelle D. Wiest(3), Linda M. Matusiak(3), Mary Kate Newell(3), Michael P. Kelly(3), Enela Aliaj(3), JoAnn Stubbings(2)